Yago Nieto, MD, PhD, discusses AFM13, how it works, and its effect as a bispecific antibody that targets CD30 and CD16.

MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer patient care, research, education, and prevention. MD Anderson has ranked among the nation's top ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades.

“That’s quite an accomplishment,” says Allison, professor and chair of immunology at The University of Texas MD Anderson Cancer Center. Ipilimumab received FDA approval for use in late-stage ...

Opens in a new tab or window Follicular lymphoma -- typically a slow ... of the University of Texas MD Anderson Cancer Center in Houston. However, he added, the evidence supporting that criteria ...

For more information, click here. From MD Anderson Cancer Center The University of Texas MD Anderson Cancer Center is one of the world's most respected centers devoted exclusively to cancer ...

Houston-based University of Texas MD Anderson Cancer Center broke ground on a new facility in Sugar Land, Texas, set to be the system’s largest location yet. Services at the new facility will ...

AUSTIN (KXAN) — The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital announced a joint venture dedicated to pediatric cancer care that is expected to launch in early ...

Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have extended and expanded a collaboration exploring medicines targeting lung cancer with KRAS mutations. The ...